SEC Form 4 · accession 0001140361-18-043651
Aquestive Therapeutics, Inc. · AQST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith J Kendall
Officer — CEO and President · Director
Period of report
Nov 21, 2018
Accepted (ET)
Nov 26, 2018 · 1:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001398733
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 21, 2018 | P | 6,000 | $10.17 | A | 618,189 | D | |
| Common Stock | Nov 23, 2018 | P | 1,950 | $9.90 | A | 620,139 | D |
Table II — derivative securities
No Table II lines on this filing.